|Year : 2015 | Volume
| Issue : 2 | Page : 144-148
Association of Mycoplasma genitalium with infertility in North Indian women
Nonika Rajkumari1, Harsimran Kaur1, Amit Roy1, Nalini Gupta2, Lakhbir Kaur Dhaliwal3, Sunil Sethi1
1 Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Department of Cytology and Gynecology Pathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
3 Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
|Date of Web Publication||12-Oct-2015|
Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh - 160 012
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Objectives: Data regarding the association of Mycoplasma genitalium with infertility is scarce. This study was planned to look for the presence and association of M. genitalium in women with infertility. Materials and Methods: A prospective observational study was conducted on 100 cases of infertile women. The control group included 100 healthy fertile women. Samples of first void urine (FVU), endocervical swabs (ECS), and endometrial biopsies were subjected to polymerase chain reaction targeting MgPa gene to look for the presence of M. genitalium DNA. All endometrial biopsy samples were subjected to histopathological examination. A detailed clinical history of patients was taken, and all relevant investigations were recorded. Results: M. genitalium was found in 16% of women with infertility from either of the samples that is, FVU and/or ECS and/or endometrium biopsy, and none from controls. ECS and biopsy could detect the highest number of cases (27%). Asymptomatic cases predominated in the study and M. genitalium positivity (73.3%) was seen more in primary infertility. Tubal occlusion and disordered proliferative endometrium were demonstrated in 33% and 26.66% of M. genitalium positive cases respectively. Conclusions: The study shows an association of M. genitalium infection and infertility and suggests routine screening of this pathogen in patients with infertility.
Keywords: India, infertility, Mycoplasma genitalium, polymerase chain reaction
|How to cite this article:|
Rajkumari N, Kaur H, Roy A, Gupta N, Dhaliwal LK, Sethi S. Association of Mycoplasma genitalium with infertility in North Indian women. Indian J Sex Transm Dis 2015;36:144-8
|How to cite this URL:|
Rajkumari N, Kaur H, Roy A, Gupta N, Dhaliwal LK, Sethi S. Association of Mycoplasma genitalium with infertility in North Indian women. Indian J Sex Transm Dis [serial online] 2015 [cited 2021 Jul 26];36:144-8. Available from: https://www.ijstd.org/text.asp?2015/36/2/144/167141
| Introduction|| |
0Mycoplasma genitalium , first isolated in 1981 is an important cause of nongonococcal urethritis (NGU) in men.  Evidence has shown that M. genitalium is sexually transmitted with a prevalence rate of 56% among male sexual partners of infected women and 32% among female partners of infected men with NGU. , Moreover, studies have indicated M. genitalium as an emerging cause of female genital tract disease.  Detection of M. genitalium is challenging as the organism is fastidious and has a long turnaround time for culture, taking months (8 weeks or more) to grow. Nucleic acid amplification tests (NAAT) are the only available diagnostic tools to identify M. genitalium.
Polymerase chain reaction (PCR) based studies have shown that M. genitalium is associated with female upper and lower genital tract disease that is, mucopurulent cervicitis, as well as endometritis, pelvic inflammatory disease (PID), and salpingitis. ,,,, M. genitalium's adherence to fallopian tube mucosal epithelial cells has been demonstrated in organ culture.  In addition, serological studies have revealed a strong association between prior M. genitalium infection and tubal factor infertility (TFI).  Serological studies are rather evidence for recent or long-term infections while NAAT studies show a link between ongoing infection and infertility.
Infertility is a growing problem and in many instances the etiological factor, particularly of infectious origin cannot be determined. Mycoplasmas can be easily overlooked as they cause low grade asymptomatic infections and there is a lack of sufficient laboratory infrastructure for diagnosing mycoplasmas in most of the hospitals in developing countries. Also, there is a lack of awareness among physicians about M. genitalium infection. There is sparse literature showing the link of M. genitalium with infertility with no report from India. This study was hence planned to look for the presence of M. genitalium in women with infertility and to investigate the causal relationship between M. genitalium and infertility.
| Materials and methods|| |
A total of 100 women with infertility who had normal montoux test, normal chest X-ray, normal hormonal level, and husband having normal semenogram attending the Infertility Clinic of Gynaecology out patient's department (OPD) of our tertiary care hospital in the North India were enrolled in the study. Infertility was defined according to the operational definition proposed by the World Health Organization as 1-year of unprotected intercourse without pregnancy, which may again be primary or secondary. Primary infertility was defined as inability of the female to conceive inspite of regular sexual intercourse for two years while secondary infertility was referred to when the female had conceived earlier but failed to do so subsequently inspite of regular exposure to sexual activity for two years.  Tubal infertility was said to be present if hydrosalpinx was seen on hysterosalpingography. Exposure to sexual activity for breastfeeding female was calculated after lactational amenorrhoea was over. All the patients on antibiotic therapy in previous 2 months were excluded from the study. One hundred healthy fertile women who had delivered recently and were attending the OPD for post natal checkup and contraceptive advice were included as controls. A detailed clinical history of the patients was taken, and all relevant investigations were recorded. A written informed consent was taken from all the patients, and the study was approved by the Institute Ethics Committee. All the specimens were blinded throughout the duration of laboratory investigations, until prior to the data analysis.
First void urine (FVU), three endocervical swabs (ECS) and endometrial biopsy samples were collected from the study group whereas only FVU and endocervical swabs were taken from the control group under strict aseptic precautions. FVU was collected and transported in a sterile plastic container and was stored at -20°C till further use. Endocervical swabs were collected from all the patients using thin Dacron swabs after thorough cleaning of the introitus with sterile normal saline. Endometrial biopsy was obtained using a curette under strict aseptic conditions under sedation with or without paracervical block. The samples were collected in normal saline for culture and in formalin for histopathological examination. The samples were transferred to laboratory in SP4 transport medium.
For Neisseria gonorrhoeae, modified New York City medium and for Mycobacterium tuberculosis, Lowenstein-Jensen medium was used for inoculation of samples. Culture of genital Mycoplasma was done by using pleuropneumonia like organism broth.  The reference strains of Ureaplasma urealyticum (NCTC 10177) and Mycoplasma hominis (NCTC10111) were used as positive controls. For Chlamydia trachomatis detection, PCR targeting 368 bp gene encoding endonuclease protein belonging to Phospholipase D superfamily was carried out.  Samples positive for C. trachomatis, M. hominis and U. urealyticum were excluded from the study.
All the samples were subjected to PCR amplification to look for the presence of M. genitalium by targeting MgPa gene as described previously by Jensen et al. , Briefly, 1.8 ml of urine was centrifuged at 20,000 × g for 15 min. The supernatant was discarded. Tubes were left for at least 1 min to let the remaining urine settle down at the bottom. Again the supernatant was pipetted out and 300 μl of Chelex 100 slurry (Sigma, USA) (20% w/v Chelex 100 in Tris-EDTA buffer [10 mmol/l Tris-HCl, pH 8.0]) was added. The mixture was vortexed vigorously for 60 s and then incubated at 95°C for 15 min. After a brief centrifugation, 10 μl of the supernatant was used for PCR.
Endocervical sample preparation for the M. genitalium PCR was performed by centrifuging 250 μl of the specimen in SP-4 medium at 30,000 × g for 15 min, resuspending the pellet in 50 μl lysis buffer with 200 μg proteinase K/ml, incubating at 55°C for 30 min, and at 94°C for 10 min. After heat treatment, 50 μl specimen diluent was added. The primers used (Sigma Aldrich Chemicals, USA) were: Forward primer (MgPa F) - 5' AGT TGA TGA AAC CTT AAC CCC TTG G 3', and Reverse Primer (MgPa R) - 5' CCG TTG AGG GGT TTT CCA TTT TTG C 3'.
A final reaction volume of 100 μl containing × 1 PCR buffer (10 mM Tris-HCI [pH 9.0], 50 mM KCl) with 4.5 mM MgCl 2 , 0.2 μM of each primer, 1U of Taq polymerase (Roche Diagnostics, Germany), 125 μM concentration of dNTP mix (Roche Diagnostics, Germany), and 50 μl of DNA extract was made. PCR was performed in a thermal cycler (Eppendorf, Germany) beginning with an initial denaturation at 95°C for 5 min, followed by a total of 35 cycles consisting of denaturation at 95°C for 1 min, annealing at 67°C for 1 min and extension at 72°C for 1 min, followed by a final extension at 72°C for 6 min. All the batches of PCR were run along with a positive control using M. genitalium DNA obtained from Statens Serum Institute, Denmark and a negative control containing all the reagents without DNA. The amplicons were visualized after electrophoresis on 2% of agarose gel stained by ethidium bromide and examined under ultraviolet transillumination for a 281 bp product. All the PCR positive were further confirmed with commercially available PCR kit (SORPOLINE™ M. genitalium End Point PCR Kit, Lithuania) for the detection of M. genitalium. The strict physical separation between samples was maintained to avoid any PCR product carryover. Endometrial biopsy preparation for PCR also was carried in a similar manner like that of the endocervical samples except that biopsy samples were minced before processing.
A part of endometrial biopsy samples was subjected to HPE which was carried out according to standard methods.
Chi-square test and Fisher's exact test were used for analyzing the results. The data were analyzed using statistical software SPSS software 15.0 (SPSS Inc., Chicago, Illinois, USA).
| Results|| |
Of the total 100 cases, C. trachomatis DNA was detected in six infertility patients negative for M. genitalium; these cases were excluded from the study. No other pathogen tested was detected in any of the specimens. Therefore, the infertility group included 94 patients. Of these 94 women, the majority were in age groups of 20-30 years. The mean age of the women was 29.08 years (±3.34) in the infertility group and 27.30 years (±3.32) in the controls. Overall, M. genitalium was detected in 16% (15/94) of women with infertility from either of the samples that is, FVU and/or ECS and/or endometrial biopsy. Most of M. genitalium positive women (60%) were from a rural background. Of 15, PCR positive M. genitalium cases, ECS, and biopsy could detect a maximum of 26.6% of the cases followed by ECS alone in 20%, endometrial biopsy alone in 20%, urine alone in 13%, and urine and ECS in 13% [Table 1]. All the three samples (urine, ECS and biopsy) were positive only in 6.6% of the patients. In the control group, none of the 100 women was M. genitalium positive from urine or ECS (P = 0.00003). The association between M. genitalium and infertility was highly significant whether the organism was detected in the cervix, urine, or endometrial biopsy or in a combination of either of the sample. M. genitalium was found to be infecting the patients without any coinfection with other pathogens tested. Asymptomatic cases (n = 77) predominated in the study. Of these asymptomatic patients, 51 (66.23%) had primary infertility while the rest had secondary infertility (33.76%). Among the 17 (21%) symptomatic patients, there were 11 (64.7%) cases of primary infertility and 6 (35.29%) cases of secondary infertility. Of the 15 women who were found to be positive for M. genitalium infection, 11 (73%) had primary infertility, while remaining 4 (26%) had secondary infertility (P < 0.001) [Table 2].
The most common symptom with infertility was discharge which was present in 12 (57%) patients, followed by burning micturition 7 (33%), scanty menses 1 (4.7%), and menorrhagia (4.7%). Amongst the women with M. genitalium infection, 40% (6/15) had history of PID as compared to 10.2% (9/88) in those without infection, and the association was statistically significant (P < 0.001) [Table 3]. Tubal occlusion was seen in 5 (33.3%) women with M. genitalium infection, and none of the women negative for M. genitalium infection had tubal occlusion (P < 0.001). All these five women were asymptomatic. M. genitalium positivity was correlated with histopathological findings, and abnormal findings which included disordered proliferative endometrium were observed in four patients of M. genitalium positive cases. However, no statistical significant difference was seen between abnormal findings in HPE and patients' positivity or negativity for M. genitalium by PCR.
|Table 1: Distribution of M. genitalium PCR results according to specimens|
Click here to view
|Table 3: Comparison of different parameters of M. genitalium PCR positive and negative women|
Click here to view
| Discussion|| |
Infertility is an emerging health problem in many countries of the world including India. In many instances of asymptomatic or oligosymptomatic infections in the patients with infertility, it is difficult to find the etiological cause. M. genitalium can be a cause of such asymptomatic infections and can be easily overlooked by clinicians. In our study, M. genitalium was found in 16% of infertile women. The higher detection may be due to the fact that three different types of samples (FVU, ECS and endometrium biopsy) were collected in this study. This is in agreement with the study by Jensen et al. which demonstrated that for the optimal sensitivity of detection of M. genitalium, two samples should be taken from women.  We found that endometrial biopsy supplemented with cervical swab could detect a maximum number of cases (27%). Another study in 51 infertility patients and 23 healthy fertile women reported high prevalence of M. genitalium in the cervical canal by PCR (20% in cases verses 4% in controls), however the results were not statistically significant. 
Most of the PCR positive M. genitalium patients were asymptomatic in our population (i.e. 81.9% [77/94] asymptomatic vs. 18% [17/94] symptomatic). The role of asymptomatic infection with genital Mycoplasma, particularly M. genitalium is known in cases of infertility caused due to fallopian tube disorders. Clausen et al. found that anti-M. genitalium antibodies were detected in 22% of women with TFI, whereas in the control group of women with unobstructed fallopian tubes, antibodies were found only in 6% of patients.  Thus, infection with M. genitalium is an independent risk factor in the development of an inflammatory process damaging the fallopian tubes causing infertility. In our study, tubal occlusion was observed in 33% of M. genitalium positive patients and none in M. genitalium negative patients. Moreover, 40% of the women in our study had a history of PID, which was found to be statistically significant (P < 0.001). In analysis of 586 women in a study which analyzed the association between M. genitalium and reproductive morbidity among population of women presenting with signs and symptoms of PID (PEACH study), the rates of sequelae were found to be high for infertility that is, 22%. These findings suggest causal relationship between M. genitalium infection and infertility, and that the detection of this particular organism is often associated with the disease and can cause permanent damage to the reproductive tract when there is chronic infection, although the symptoms are very mild. ,,
We observed that the incidence of M. genitalium was more common in women with primary infertility as compared to secondary infertility though this finding was not statistically significant. Surprisingly, we observed that M. genitalium was detected in our patients without any co-infection with other common pathogens. This further suggests that M. genitalium infection could be the primary pathogen responsible for infertility. The study also demonstrated that more than one sample that is, urine and ECS and/or endometrial biopsy are needed to increase the detection rate of M. genitalium in infertility patients. However, the studies with larger sample size are needed to further elucidate the extent and severity of infertility caused by M. genitalium.
C. trachomatis had low positivity of 0.6% in the present study. A study from Aligarh, India has shown the presence of C. trachomatis in 28.1% of infertile women while, in another study, anti-chlamydial IgG antibodies were detected in 68% of women with infertility. , The low detection of this pathogen in our study may be due to our center being a tertiary care center and patients referred here are already exposed to many antibiotics including doxycycline and azithromycin to which C. trachomatis is sensitive.
The detection of M. genitalium infection in infertile couples is still not included in the standard tests performed for infertility because there is scanty evidence of association of M. genitalium with infertility; also, there is lack of awareness among clinicians regarding infertility due to M. genitalium infection. The present study clearly indicates the link between M. genitalium infection and infertility and our findings strongly suggest that clinicians should raise their index of suspicion for M. genitalium infection as an etiological agent when treating infertility and such patients should be routinely screened for M. genitalium even if they are not symptomatic.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered Mycoplasma
in the human urogenital tract. Lancet 1981;1:1288-91.
Manhart LE, Critchlow CW, Holmes KK, Dutro SM, Eschenbach DA, Stevens CE, et al.
Mucopurulent cervicitis and Mycoplasma genitalium
. J Infect Dis 2003;187:650-7.
Cohen CR, Nosek M, Meier A, Astete SG, Iverson-Cabral S, Mugo NR, et al. Mycoplasma genitalium
infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007;34:274-9.
Jensen JS. Mycoplasma genitalium
: The aetiological agent of urethritis and other sexually transmitted diseases. J Eur Acad Dermatol Venereol 2004;18:1-11.
Taylor-Robinson D. Mycoplasma genitalium
- An up-date. Int J STD AIDS 2002;13:145-51.
Falk L, Fredlund H, Jensen JS. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium
or Chlamydia trachomatis
infection. Sex Transm Infect 2005;81:73-8.
Taylor-Robinson D, Furr PM. Update on sexually transmitted mycoplasmas. Lancet 1998;351 Suppl 3:12-5.
Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC, Holmes KK, et al.
Association between Mycoplasma genitalium
and acute endometritis. Lancet 2002;359:765-6.
Taylor-Robinson D. The Harrison Lecture. The history and role of Mycoplasma genitalium
in sexually transmitted diseases. Genitourin Med 1995;71:1-8.
Baczynska A, Friis Svenstrup H, Fedder J, Birkelund S, Christiansen G. The use of enzyme-linked immunosorbent assay for detection of Mycoplasma hominis
antibodies in infertile women serum samples. Hum Reprod 2005;20:1277-85.
Cole B. Mycoplasma
interactions with the immune system: Implications for disease pathology. ASM News 1996;62:471-5.
Marimion BP, Harris RJ. Mycoplasma pneumoniae
and other medically important members of the family Mycoplasmataceae
. In: Colee JG, Fraser AG, Marmion BP, Simmon SA, editors. Mackie and McCartney Practical Medical Microbiology. 14 th
ed., Vol. II. Edinburgh: Churchill Livingstone; 1996. p. 591-620.
Sachdeva P, Patel AL, Sachdev D, Ali M, Mittal A, Saluja D. Comparison of an in-house PCR assay, direct fluorescence assay and the Roche AMPLICOR Chlamydia trachomatis
kit for detection of C. trachomatis
. J Med Microbiol 2009;58(Pt 7):867-73.
Jensen JS, Uldum SA, Søndergård-Andersen J, Vuust J, Lind K. Polymerase chain reaction for detection of Mycoplasma genitalium
in clinical samples. J Clin Microbiol 1991;29:46-50.
Jensen JS, Borre MB, Dohn B. Detection of Mycoplasma genitalium
by PCR amplification of the 16S rRNA gene. J Clin Microbiol 2003;41:261-6.
Jensen JS, Björnelius E, Dohn B, Lidbrink P. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium
and Chlamydia trachomatis
by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis 2004;31:499-507.
Grzesko J, Elias M, Maczynska B, Kasprzykowska U, Tlaczala M, Goluda M. Occurrence of Mycoplasma genitalium
in fertile and infertile women. Fertil Steril 2009;91:2376-80.
Clausen HF, Fedder J, Drasbek M, Nielsen PK, Toft B, Ingerslev HJ, et al.
Serological investigation of Mycoplasma genitalium
in infertile women. Hum Reprod 2001;16:1866-74.
Anagrius C, Loré B, Jensen JS. Mycoplasma genitalium
: Prevalence, clinical significance, and transmission. Sex Transm Infect 2005;81:458-62.
Falk L, Fredlund H, Jensen JS. Symptomatic urethritis is more prevalent in men infected with Mycoplasma genitalium
than with Chlamydia trachomatis
. Sex Transm Infect 2004;80:289-93.
Malik A, Jain S, Hakim S, Shukla I, Rizvi M. Chlamydia trachomatis
infection and female infertility. Indian J Med Res 2006;123:770-5.
Sharma K, Aggarwal A, Arora U. Seroprevalence of Chlamydia trachomatis
in women with bad obstetric history and infertility. Indian J Med Sci 2002;56:216-7.
[Table 1], [Table 2], [Table 3]